ADI PEG20 clinical trials

Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)

This study is looking for people with a type of cancer called leiomyosarcoma (LMS) that has already been treated. It's testing a new medicine (ADI-PEG 20) against a dummy medicine (placebo) alongside standard treatments to see if it's safe and helps improve outcomes.